Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|August 18, 2016
Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trialEspen A Haavardsholm, Anna-Birgitte Aga, Inge Christoffer Olsen, et al.
Annals of the Rheumatic Diseases|August 22, 2023
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trialSiri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2024
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis BAsgeir Johannessen, Dag Henrik Reikvam, Soo Aleman, et al.
British Journal of Clinical Pharmacology|January 21, 2023
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortiaVida Terzić, Léa Levoyer, Mélanie Figarella, et al.
Scientific Reports|December 2, 2021
Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9Tøri Vigeland Lerum, Niklas Nyboe Maltzahn, Pål Aukrust, et al.
Lancet (London, England)|June 26, 2022
Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trialHåvard Ove Skjerven, Anine Lie, Riyas Vettukattil, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Journal of Internal Medicine|February 25, 2022
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterationsBeate Vestad, Thor Ueland, Tøri Vigeland Lerum, et al.
Lancet (London, England)|February 23, 2020
Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trialHåvard Ove Skjerven, Eva Maria Rehbinder, Riyas Vettukattil, et al.
JAMA|May 4, 2021
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical TrialSilje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.
Pageof 5